These findings differ from studies such as that by Thobbi et al., where the OI group showed a marked increase in Hb, suggesting that the treatment duration and frequency may have influenced the observed differences in Hb levels [14]. This evidence concerns the gene GSTM1 and osteogenesis imperfecta.